Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10191-10198

  Brander, Christian ^a,g   Yang, Otto O ^a   Jones, Norman G ^a   Lee, Yun ^a   Goulder, Philip ^a   Johnson, R Paul ^a   Trocha, Alicja ^a   Colbert, David ^b   Hay, Christine ^a   Buchbinder, Susan ^b   Bergmann, Cornelia C ^c   Zweerink, Hans J ^d   Wolinsky, Steven ^e   Blattner, William A ^f   Kalams, Spyros A ^a   Walker, Bruce D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HIV Research Section   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VACCINIA VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0032757187     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10191-10198.1999     Document Type: Article

References (54)

1. Androlewicz, M. J., and P. Cresswell. 1996. How selective is the transporter associated with antigen processing? Immunity 5:1-5.
2. Bergmann, C. C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:5306-5310.
3. Bergmann, C. C., Q. Yao, C. Ho, and S. L. Buckwold. 1996. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157:3242-3249.
4. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
5. Brander, C., K. E. Hartman, A. K. Trocha, N. G. Jones, R. P. Johnson, B. Korber, P. Wentworth, S. P. Buchbinder, S. Wolinsky, B. D. Walker, and S. A. Kalams. 1998. Lack of strong immune selection pressure by the immunodominant. HLA-A*0201-restricted CTL response in chronic HIV-1 infection. J. Clin. Investig. 101:2559-2566.
6. Brander, C., and B. D. Walker. 1996. The HLA class I restricted CTL response in HIV infection: systematic identification of optimal epitopes. In B. Korber, C. Brandet, B. Walker, R. Koup, J. Moore, B. Haynes, and G. Meyers (ed.), HIV molecular immunology database. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, N.Mex. http://hiv-web.lanl.gov/immunology/index.html. [6 October 1999, last date accessed.]
7. Cannon, P. M., S. Matthews, N. Clark, E. D. Byles, O. Iourin, D. J. Hockley, S. M. Kingsman, and A. J. Kingsman. 1997. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J. Virol. 71:3474-3483.
8. Chen, Z. W., L. Shen, M. D. Miller, S. H. Ghim, A. L. Hughes, and N. L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149:4060-4066.
9. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129-1134.
10. Cucchiarini, M., S. Barcellini-Couget, J. C. Lefebvre, and A. Doglio. 1998. T cells chronically infected with HIV-1 do not contain sufficient Nef to promote CD4 downmodulation in the absence of envelope mediated effects. J. Acquir. Immune Defic. Syndr. 17:112-119.
11. Daniel, S., S. Caillat-Zucman, J. Hammer, J. F. Bach, and P. M. van Endert. 1997. Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection. J. Immunol. 159: 2350-2357.
12. Davenport, M. P. 1995. Antagonists or altruists: do viral mutants modulate T cell responses? Immunol. Today 16:432-437.
13. Del Val, M., H.-J. Schlicht, T. Ruppert, M. J. Reddehase, and U. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell 66:1145-1153.
14. Eggers, M., B. Boes-Fabian, T. Ruppert, P. M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865-1870.
15. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
16. + nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1167-1173.
17. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
18. Goulder, P. J. R., A. K. Sewell, D. G. Lalloo, D. A. Price, J. A. Whelan, J. Evans, G. P. Taylor. G. Luzzi, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1997. Patterns of immunodominance in HIV-1-speciflc cytotoxic T lymphocyte responses on two human histocompatibility leukocyte antigen identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423-1433.
19. Hay, C. M., D. J. Ruhl, N. Basgoz, C. C. Wilson, J. M. Billingsley, M. P. DePasquale, R. D'Aquila, S. Wolinsky, J. M. Crawford, D. Montefiori, and B. D. Walker. 1999. Lack of viral escape and defective in vivo activation of HIV-1-specific CTL in rapidly progressive infection. J. Virol. 73:5509-5519.
20. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
21. Kaegi, D., B. Ledermann, K. Buerki, R. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232.
22. Kalams, S. A., S. P. Buchbinder, E. S. Rosenberg, J. M. Billingsley, D. S. Colbert, N. G. Jones, A. K. Shea, A. K. Trocha, and B. D. Walker. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 Infection. J. Virol. 73:6715-6720.
23. Karacostas, V., E. J. Wolffe, K. Nagashima, M. A. Gonda, and B. Moss. 1993. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193:661-671.
24. Klenerman, P., S. Rowland-Jones, S. McAdam. J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giagrande, R. E. Phillips, and A. J. McMichael. 1994. Naturally occurring HIV-1 gag variants antagonise cytotoxic T cell activity. Nature 369:403-410.
25. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, C. Wannebo, J. R. Yanelli, S. A. Rosenberg, and H. C. Lane. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1:330-336.
26. Korber, B., B. Walker, C. Brander, R. Koup, J. Moore, B. Haynes, and G. Meyers. 1998. HIV molecular immunology database 1998. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, N.Mex.
27. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
28. Marti, W. R., P. Zajac, G. Spagnoli, M. Haberer, and D. Oertli. 1997. Nonreplicating recombinant vaccinia virus encoding human B7 molecules elicits effective costimulation of naive and memory CD4 T lymphocytes in vitro. Cell. Immunol. 179:146-152.
29. McMichael, A. 1998. T cell responses and viral escape. Cell 93:673-676.
30. McMichael, A.J., C. A. Michie, F. M. Gotch, G. L. Smith, and B. Moss. 1986. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Virol. 67:719-726.
31. Meyers, G., B. Foley, J. W. Mellors, B. Korber, K. Jeang, and S. Wain-Hobson. 1996. Human retroviruses and AIDS 1996: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratories: Theoretical Biology, Los Alamos, N.Mex. http://hiv-web.lanl.gov. [6 October 1999, last date accessed.]
32. Momburg, F., J. Roelse, J. C. Howard, et al. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648-651.
33. Neisig, A., J. Roelse, A. J. Sijts, F. Ossendorp, M. C. Feltkamp, W. M. Kast, C. J. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273-1279.
34. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289-299.
35. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P. Kloetzel, J. Neefjies, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115-124.
36. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463-467.
37. Price, D. A., P. J. R. Goulder, P. Klenerman, A. Sewell, P. J. Easterbrook, M. Troop, C. R. M. Bangham, and R. E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94:1890-1895.
38. + T cell responses associated with control of viremia. Science 278:1447-1450.
39. Rutherford, G. W., A. R. Lifson, N. A. Hessol, W. W. Darrow, P. M. O'Malley, S. P. Buchbinder, J. L. Barnhart, T. W. Bodecker, L. Cannon, L. S. Doll, et al. 1990. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. Br. Med. J. 301:1183-1188.
40. Sipsas, N. V., S. A. Kalams, A. Trocha, S. He, W. A. Blattner, B. D. Walker, and R. P. Johnson. 1997. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with the human immunodeficiency virus-1. J. Clin. Investig. 99:752-762.
41. Suhrbier, A. 1997. Multi-epitope DNA vaccines. Immunol. Cell Biol. 75:402-408.
42. Thomson, S. A., S. L. Elliott, M. A. Sherritt, K. W. Sproat, B. E. Coupar, A. A. Scalzo, C. A. Forbes, A. M. Ladhams, X. Y. Mo, R. A. Tripp, P. C. Doherty, D. J. Moss, and A. Suhrbier. 1996. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 157:822-826.
43. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I restricted cytotoxic T lymphocytes in vaccinia infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
44. Van Endert, P., D. Riganelli, G. Greco, K. Fleischbauer, J. Sidney, A. Sette, and J. Bach. 1995. The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182:1883-1895.
45. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348.
46. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64-66.
47. Weiss, S. H., J. J. Goedert, S. Gartner, M. Popovic, D. Waters, P. Marham, F. di Marzo Veronese, M. H. Gail, W. E. Barkley, J. Gibbons, F. A. Gill, M. Leuther, G. M. Shaw, R. C. Gallo, and W. A. Blattner. 1988. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science 239:68-71.
48. + cells: evidence for HLA class 1-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
49. Yang, O. O., A. C. Trocha, S. A. Kalams, R. P. Johnson, M. R. Roberts, and B. D. Walker. 1997. Lysis of HIV-1 infected cells and inhibition of viral replication by universal receptor T cells. Proc. Natl. Acad. Sci. USA 94: 11478-11483.
50. Yang, O. O., and B. D. Walker. 1997. CD8 cells in human immunodeficiency virus type 1 pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.
51. Yellen-Shaw, A. J., C. E. Laughlin, R. M. Metrione, and L. C. Eisenlohr. 1997 Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses. J. Exp. Med. 186:1655-1662.
52. Yellen-Shaw, A. J., E. J. Wherry, G. C. Dubois, and L. C. Eisenlohr. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227-3234.
53. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:71-82.
54. Zweerink, H. J., M. C. Gammon, U. Utz, S. Y. Sauma, T. Harrer, J. C. Hawkins, R. P. Johnson, A. Sirotina, J. D. Hermes, B. D. Walker, et al. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763-1771.